History of
Convergent Engineering
• 1992 Neil Euliano joins the University of Florida Anesthesiology Computer Engineering Team (FACET) developing control circuits and algorithms for a transport ventilator.
• 1998 Neil Euliano joins NeuroDimension (ND), a neural network software company, and starts the Biomedical Research Division.
• 1999 ND receives NSF grant to study neural network controlled ventilators.
• 2000 ND is granted first patent for intelligent ventilator control system.
• 2002 ND receives NSF grant to study information theoretic (blind source separation) approaches to extracting fetal heart rate from maternal abdominal electrodes.
• 2002 ND licenses ventilator technology to Respironics and begins long term R&D agreement.
• 2003 ND begins working with UF team that eventually creates xHale Diagnostics. Projects include novel pulse oximetry signal processing and electronic nose technology.
• 2004 Convergent Engineering formed after Neil Euliano purchases rights to IP and technology from ND.
• 2005 Convergent Engineering begins development of electronic pill technology for medication compliance under grant from NSF.
• 2005 Tyco Healthcare licenses fetal monitoring technology from CE. Convergent Engineering signs 3-year R&D agreement with Tyco to commercialize technology.
• 2006 Tyco is dismantled and R&D agreement and license for fetal monitoring technology are terminated.
• 2007 Philips Healthcare acquires Respironics and Convergent Engineering technology and R&D agreement
• 2009 CE's Tenth US patent Issued.
• 2009 Convergent Engineering spins off eTect Inc to commercialize electronic pill technology. Convergent signs R&D agreement with eTect to help develop technology.
• 2010 Convergent Engineering signs R&D agreement to help xHale Diagnostics commercialize pulse oximetry technology.​
• 2011 VentAssist decision support technology receives FDA clearance as part of Philips NM3 respiratory monitor​
• 2012 CE's 20th US patent Issued.
• 2012 Convergent Engineering licenses fetal monitoring IP and technology to new startup OBMedical. Convergent signs R&D agreement with OBMedical to help commercialize the technology.
• 2013 Convergent Engineering begins developing non-invasive preeclampsia detection and prediction technology under grants from USAID and NIH.
• 2014 CE's 30th US patent Issued.
• 2015 Convergent Engineering's fetal monitoring technology receives FDA clearance as part of OBMedical's LaborView fetal monitoring system.
• 2016 eTect is acquired and etectRx formed to commercialize ID-Cap medication compliance system.
• 2018 CE's 40th US patent Issued.
• 2018 Patent technology co-developed by Convergent Engineering purchased during Philips Healthcare acquisition of xHale Assurance.
• 2018 Technology and patents created by Convergent Engineering acquired by Philips Healthcare during acquisition of OBMedical.